cilostazol has been researched along with mastoparan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Achilleus, D; Bowles, EA; Ellis, CG; Ellsworth, ML; Sprague, RS; Stephenson, AH | 1 |
1 other study(ies) available for cilostazol and mastoparan
Article | Year |
---|---|
A selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control.
Topics: Adenosine Triphosphate; Adult; Animals; Arterioles; Case-Control Studies; Cilostazol; Cricetinae; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Diabetes Mellitus, Type 2; Erythrocytes; Female; Humans; Intercellular Signaling Peptides and Proteins; Male; Mesocricetus; Microcirculation; Middle Aged; Missouri; Muscle, Skeletal; Oxygen; Peptides; Phosphodiesterase 3 Inhibitors; Tetrazoles; Vasodilation; Vasodilator Agents; Wasp Venoms; Young Adult | 2011 |